40 results on '"Covut, Fahrettin"'
Search Results
2. Duvelisib for Critically Ill Patients With Coronavirus Disease 2019: An Investigator-Initiated, Randomized, Placebo-Controlled, Double-Blind Pilot Trial
3. Mitigating the risk of venous thromboembolism in patients with multiple myeloma receiving immunomodulatory-based therapy
4. Early Onset of Smoldering Disease Correlates with Rapid Progression to Symptomatic Multiple Myeloma
5. Duvelisib for Critically-Ill Patients with COVID-19 Disease: An Investigator-Initiated, Randomized, Placebo-Controlled Double-Blind Pilot Trial
6. Gastrointestinal Toxicities of Immune Checkpoint Inhibitors Are Associated With Enhanced Tumor Responsiveness and Improved Survival
7. Heparin-Induced Thrombocytopenia in a Patient With Coronavirus Disease-19
8. Clinical Characteristics and Outcomes of Primary Breast Lymphoma: The Cleveland Clinic Experience
9. Prevalence and Predictors of Gastrointestinal Dysmotility in Patients with Hypermobile Ehlers-Danlos Syndrome: A Tertiary Care Center Experience
10. Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
11. OUTCOMES OF TRANSCATHETER AORTIC VALVE REPLACEMENT IN TRANSPLANT RECIPIENTS
12. Equivocal Significance of Prior Malignancies to Predict Overall Survival of Multiple Myeloma Patients after Autologous Hematopoietic Cell Transplant
13. Value and Cost Effectiveness of Storing Peripheral Blood Progenitor Cells for Salvage Autologous Stem Cell Transplant in Multiple Myeloma
14. Impact of Previous Cancer Therapy on Outcome of Patients with Multiple Myeloma or Smoldering Disease
15. External Validation of the Impede VTE Risk Score in Newly Diagnosed Multiple Myeloma (MM) Patients
16. Risk of Intracerebral Hemorrhage with and without Anticoagulation in Patients with Brain Metastasis: The Cleveland Clinic Experience
17. Meta-Analyses of Clinical Trials Comparing the Progression Free Survival and Adverse Events in Treated Versus Observed Patients with Smoldering and Indolent Multiple Myeloma
18. Risk of Progression in Patients with Smoldering Myeloma
19. Mo1479 – Evaluation of Prognostic Models in Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid
20. Su2012 – Etiology of and Predictive Factors for Chronic Intestinal Failure Requiring Long Term Parenteral Nutrition in the Last Two Decades; a Tertiary Centre Experience
21. Hand-foot Syndrome Secondary to Low-dose Docetaxel in a Breast Cancer Patient
22. Peri-Transplant Venous Thromboembolism in Patients with Multiple Myeloma
23. Simultaneous Presentation of Waldenström's Macroglobulinemia and MYD88 Gene Mutation with Multiple Myeloma
24. Late Central Nervous System Relapse in a Patient with Maxillary Sinus Lymphoma
25. Outcomes Associated with Therapeutic Anticoagulation in Patients with Brain Metastasis
26. Sa1588 - Prevalence and Predictors of Gastrointestinal Dysmotility in Patients with Ehlers-Danlos Syndrome, Hypermobility type (Eds-Ht): A Tertiary Center Experience
27. Tu1541 - Diagnostic Accuracy and Optimal Cut-Off Values of Transient Elastography (Fibroscan) and AST to Platelet Ratio Index (APRI) in Diagnosis of Clinical Cirrhosis
28. Reducing Gastrointestinal Toxicity Associated with Autologous Transplantation for Multiple Myeloma without Compromising Its Anti-Myeloma Effect
29. Does PBSC Product Platelet Content Affect Outcomes of Autologous Peripheral Blood Stem Cell Transplant?
30. Impact of Lenalidomide on Hematopoietic Myeloid and Erythroid Progenitors: Peripheral Stem Cell Collection May Not be Affected
31. Immunologic Status Evaluated By the Absolute Lymphocyte/Monocyte Ratio Provides a Powerful Prognostic Tool for Newly Diagnosed Multiple Myeloma
32. Rethinking Risk-Benefit Assessment for Phase I Multiple Myeloma Trials
33. Low Dose Antithymocyte Globulin (ATG) for Graft-Versus-Host Disease (GVHD) Prophylaxis
34. Plerixafor Overcomes Lenalidomide-Associated Stem Cell Collection Failure and Affects Collected Myeloid and Erythroid Progenitors
35. Prognostic Impact of Morphological Cellularity in Early Assessment Bone Marrow Biopsy after 7+3 Induction in Patients with Acute Myeloid Leukemia
36. 193 - Does PBSC Product Platelet Content Affect Outcomes of Autologous Peripheral Blood Stem Cell Transplant?
37. 194 - Impact of Lenalidomide on Hematopoietic Myeloid and Erythroid Progenitors: Peripheral Stem Cell Collection May Not be Affected
38. Effect of Histologic Grade on Clinical Outcomes of Follicular Lymphoma: Prolonged Progression Free Survival of Grade 3 Follicular Lymphoma in the Rituximab Era
39. Central Nervous System Relapse in Diffuse Large B Cell Lymphoma—Predictors at Diagnosis
40. Evaluation of the United Kingdom-primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.